Strategic Investment Advisors / MI
Position in LLY — ELI LILLY & Co
CIK 1760540
FARMINGTON HILLS, MI
Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,849,845
+$444,647 QoQ
Shares Held
2,376
-9.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#2,174
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Advisors / MI holds $15,039,322 across 11 Drug Manufacturers - General names. LLY ranks #2 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,165 | $3,564,480 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,376 | $2,849,845 | |
| 3 | AMGN |
Amgen Inc
|
7,664 | $2,775,287 | |
| 4 | PFE |
Pfizer Inc
|
48,044 | $1,156,899 | |
| 5 | JNJ |
Johnson & Johnson
|
4,524 | $1,148,960 | |
| 6 | SNY |
Sanofi
|
25,867 | $1,103,486 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,694 | $860,179 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,340 | $674,655 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,849,845 | 2,376 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,405,198 | 2,615 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $2,176,227 | 2,025 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,617,560 | 2,120 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $1,797,596 | 2,306 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,070,556 | 2,507 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,992,532 | 2,581 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,167,895 | 2,447 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,269,787 | 2,507 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,955,013 | 2,513 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,503,933 | 2,580 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,199,948 | 2,234 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $940,304 | 2,005 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $757,584 | 2,206 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $725,826 | 1,984 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,790,712 | 5,538 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,626,661 | 5,017 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,335,916 | 4,665 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,074,219 | 3,889 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $794,580 | 3,439 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $732,168 | 3,190 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,122,227 | 6,007 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,935,412 | 11,463 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $399,209 | 2,697 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $245,449 | 1,495 | Shares | Sole | 2020-08-04 | |
| No filing history on record for this holder in this stock. | ||||||